CRISPR gene-editing therapies need more diverse DNA to realize their full potential
The genetic data that underpins CRISPR has a big diversity problem.
Stay updated with breaking news from Luca Pinello. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The genetic data that underpins CRISPR has a big diversity problem.
The approval of the first DNA editing therapy opens the door to a revolution in the treatment of a multitude of diseases, such as cancer
Gene editing holds enormous promise for tackling devastating diseases, according to experts who spoke at Harvard Chan School's PQG conference.
Stability AI, the company behind Stable Diffusion, is backing a community effort to apply AI techniques to biomedicine.
A team led by investigators at Massachusetts General Hospital (MGH) has overcome a major constraint for cutting and editing DNA by CRISPR-Cas enzymes and other technologies.